Ontario announces $741 million diabetes strategy Nevanac: new ophthalmic NSAID coming soon Forteo approved for severe steroid-induced osteoporosis Codeine too risky for breastfed infants Coming soon: new IV cephalosporin active against MRSA CVS Caremark to acquire Longs Drug Stores Low vitamin D levels associated with increased mortality “Non-dairy” acidophilus products: milk allergy warning Uncertainty regarding ezetimibe and cancer risk Drug News: July/August 2008 Stalevo: new combo for Parkinson’s disease; Vectibix for colorectal cancer. First Previous 2187 2188 2189 2190 2191 Next Last
